Drug · DIN 02390965
IPG-GABAPENTIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 17, 2016.
- Drug Identification Number (DIN)
- 02390965
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- November 13, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 17, 2016: NOC 33952Abbreviated New Drug Submission (ANDS) · Bristol-Myers Squibb/Sanofi-Synthelabo Canada Inc.,
- August 28, 2012: NOC 13591Abbreviated New Drug Submission (ANDS)
Other DINs named IPG-GABAPENTIN
- DIN 02390949 · Approved
- DIN 02390957 · Approved